Browsing by Author Minden, Mark D.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 12 of 12
TitleAuthor(s)Issue Date
 
Breakpoints in the human T-cell antigen receptor α-chain locus in two T-cell leukaemia patients with chromosomal translocations
Journal:Nature
Lewis, William H.Michalopoulos, Effie E.Williams, Dorothy L.Minden, Mark D.Mak, Tak W.
1985
 
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations
Journal:Journal of Experimental Medicine
Gross, StefanCairns, Rob A.Minden, Mark D.Driggers, Edward M.Bittinger, Mark A.Jang, Hyun GyungSasaki, MasatoJin, ShengfangSchenkein, David P.Su, Shinsan M.Dang, LennyFantin, Valeria R.Mak, Tak W.
2010
 
Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and TAL-1 (SCL)
Journal:Blood
Lowsky, RobertDeCoteau, John F.Reitmair, Armin H.Ichinohasama, RyoDong, Wei FengXu, YiMak, Tak W.Kadin, Marshall E.Minden, Mark D.
1997
 
Distinct and opposite effects of leukemogenic Idh and Tet2 mutations in hematopoietic stem and progenitor cells
Journal:Proceedings of the National Academy of Sciences
Fortin, JeromeChiang, Ming FengMeydan, CemFoox, JonathanRamachandran, ParameswaranLeca, JulieLemonnier, FranҫoisLi, Wanda Y.Gams, Miki S.Sakamoto, TakashiChu, MandyTobin, ChantalLaugesen, EricRobinson, Troy M.You-Ten, AnnickButler, Daniel J.Berger, ThorstenMinden, Mark D.Levine, Ross L.Guidos, Cynthia J.Melnick, Ari M.Mason, Christopher E.Mak, Tak W.
24-Jan-2023
 
FCHSD2 predicts response to chemotherapy in acute myeloid leukemia patients
Journal:Leukemia Research
Han, YouqiCui, JieLu, YanSue, StephanieArpaia, EnricoMak, Tak W.Minden, Mark D.
2012
 
Inhibition of glycolysis as a therapeutic strategy in acute myeloid leukemias
Book:Targeted Therapy of Acute Myeloid Leukemia
Laister, Rob C.Minden, Mark D.Mak, Tak W.
2015
 
Opposing effects of NPM1wt and NPM1c mutants on AKT signaling in AML
Journal:Leukemia
Ren, ZhuoShrestha, MariuszSakamoto, TakashiMelkman, TaliMeng, LiCairns, Rob A.Zacksenhaus, EldadMak, Tak W.Stambolic, VukMinden, Mark D.Wang, Jiance Atom
2020
 
Organization and sequences of the variable, joining and constant region genes of the human T-cell receptor α-chain
Journal:Nature
Yoshikai, YasunobuClark, Stephen P.Taylor, SheryleSohn, UikWilson, Bonnie I.Minden, Mark D.Mak, Tak W.
1985
 
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms
Journal:Leukemia
Murphy, TracyMason, Jacqueline M.Leber, BrianBray, Mark R.Chan, Steven M.Gupta, VikasKhalaf, DinaMaze, DawnMcNamara, Caroline J.Schimmer, Aaron D.Schuh, Andre C.Sibai, HassanTrus, MichaelValiquette, DebbieMartin, KylieNguyen, LinhLi, XuanMak, Tak W.Minden, Mark D.Yee, Karen W.L.
1-Mar-2024
 
Sequences and diversity of human T cell receptor β chain variable region genes
Journal:Journal of Experimental Medicine
Kimura, NobuhiroToyonaga, BarryYoshikai, YasunobuTriebel, FredericDebre, PatriceMinden, Mark D.Mak, Tak W.
1986
 
Structure and rearrangement of the T cell receptor J alpha locus in T cells and leukemic T cell lines
Journal:European Journal of Immunology
Champagne, EricSagman, UriBiondi, AndreaLewis, William H.Mak, Tak W.Minden, Mark D.
1988
 
T cell receptor and immunoglobulin gene rearrangements in acute myeloblastic leukemia
Journal:Journal of Experimental Medicine
Cheng, Gregory Y.Minden, Mark D.Toyonaga, BarryMak, Tak W.McCulloch, Ernest A.
1986
Showing results 1 to 12 of 12